Merit Medical Systems (MMSI) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.12
- Estimate
- $1.04
- Surprise
- +7.8%
- Revenue (period 2026-09-30)
- $416.2M
- Score at report (before → after)
- 5.7 → 5.8/10
Revenue source: xbrl.
How the report landed
Merit Medical Systems (MMSI) beat the $1.04 estimate with adjusted EPS of $1.12 — a clear 7.8% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.7/10) to Hold at 5.8/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates MMSI Hold at 5.9/10.
4 of the last 4 quarters beat the estimate; this quarter's +7.8% surprise compares with a +13.4% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Analyst target reached - limited upside remaining
- Near 52-week high (1.5% away)
- Target reached (-6.2% upside)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $93.39
- Stop
- $88.75
The stock trades at 38.4× trailing but 20.2× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-10-30 — shown for context, not personalized investment advice.
MMSI at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $5.58B
- P/E (fwd)
- 20.2
- P/E (ttm)
- 38.4
- 52-week range
- $59.74–$94.85
- Off 52-week high
- 1.5%
- RSI (14)
- 68
- Volume vs avg
- 1.47×
- Score today
- 5.9/10